Tempus AI, Inc. (NASDAQ:TEM) Receives Consensus Rating of “Moderate Buy” from Analysts

Tempus AI, Inc. (NASDAQ:TEM) has earned a consensus rating of “Moderate Buy” from the ten brokerages that are currently covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $54.22.

Several brokerages have commented on TEM. Loop Capital upped their target price on shares of Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research note on Tuesday, October 15th. Needham & Company LLC restated a “buy” rating and issued a $47.00 price objective on shares of Tempus AI in a research report on Wednesday, August 7th. Bank of America downgraded Tempus AI from a “buy” rating to a “neutral” rating and raised their price objective for the stock from $45.00 to $60.00 in a research note on Wednesday, October 2nd. Piper Sandler reiterated a “neutral” rating and issued a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a report on Tuesday. Finally, Stifel Nicolaus cut shares of Tempus AI from a “buy” rating to a “hold” rating and boosted their price objective for the company from $45.00 to $65.00 in a research report on Monday, November 11th.

Tempus AI Price Performance

TEM opened at $52.40 on Monday. The business’s 50 day simple moving average is $51.25. Tempus AI has a fifty-two week low of $22.89 and a fifty-two week high of $79.49. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17.

Institutional Trading of Tempus AI

Several large investors have recently made changes to their positions in TEM. EFG Asset Management North America Corp. acquired a new position in shares of Tempus AI during the second quarter worth $1,333,000. ARK Investment Management LLC bought a new position in shares of Tempus AI during the second quarter worth about $18,294,000. Northwestern University acquired a new position in shares of Tempus AI in the 2nd quarter worth approximately $491,000. Alphabet Inc. acquired a new position in Tempus AI in the second quarter valued at $54,289,000. Finally, Pier Capital LLC acquired a new position in shares of Tempus AI in the 2nd quarter valued at about $2,301,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.